Physician profile
Sonia A Eapen
NPI 1427242171
$17,882.03
in general payments reported to CMS, 2019-2025
63 companies · $2,681 in 2025
The $2,681 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,182 · 2020: $3,074 · 2021: $1,753 · 2022: $2,387 · 2023: $2,486 · 2024: $2,319 · 2025: $2,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,370 · Education: $99.00 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,369.93 |
| Education | $99.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $2,623.12 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $2,055.39 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,913.04 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $1,675.66 | 2019-2025 | Farxiga |
| Amgen INC. | $885.26 | 2019-2025 | Repatha, Tepezza, Repatha |
| Sanofi-Aventis U.S. LLC | $818.78 | 2019-2025 | |
| Abbvie INC. | $799.74 | 2019-2025 | Synthroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $693.23 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Antares Pharma, INC. | $596.50 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Dexcom, INC. | $521.86 | 2019-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $457.24 | 2019-2025 | Freestyle Libre 3 |
| Mannkind Corporation | $441.51 | 2019-2025 | Afrezza |
| Insulet Corporation | $376.97 | 2019-2025 | Omnipod |
| Cequr Corporation | $373.85 | 2022-2025 | Cequr Simplicity |
| Amneal Pharmaceuticals LLC | $337.89 | 2019-2025 | Unithroid |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $333.33 | 2024-2025 | Korlym |
| Radius Health, INC. | $228.73 | 2019-2025 | Tymlos |
| Ibsa Pharma INC. | $204.22 | 2019-2025 | Tirosint, Licart, Tirosint |
| Ascendis Pharma Endocrinology INC | $198.27 | 2023-2025 | Yorvipath |
| Novartis Pharmaceuticals Corporation | $191.99 | 2022-2024 | |
| Embecta Corp. | $189.53 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Bayer Healthcare Pharmaceuticals INC. | $128.81 | 2022-2023 | |
| Astellas Pharma US INC | $120.76 | 2025 | Veozah |
| Amphastar Pharmaceuticals, INC. | $114.90 | 2024-2025 | |
| Companion Medical, INC. | $114.01 | 2019-2020 | |
| Halozyme INC | $106.27 | 2023 | |
| Beta Bionics, INC. | $101.26 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Madrigal Pharmaceuticals | $93.83 | 2025 | Rezdiffra |
| Averitas Pharma INC. | $82.77 | 2025 | Qutenza |
| Janssen Pharmaceuticals, INC | $76.84 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $71.31 | 2021-2023 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $63.64 | 2020-2021 | |
| Ascensia Diabetes Care US INC. | $60.24 | 2023-2024 | |
| Kyowa Kirin, INC. | $53.47 | 2025 | |
| Acella Pharmaceuticals, LLC | $50.13 | 2025 | NP Thyroid 60 |
| Verity Pharmaceuticals INC. | $49.87 | 2024-2025 | Tlando |
| Becton, Dickinson and Company | $48.65 | 2021-2022 | |
| Lifescan, INC. | $48.48 | 2019-2020 | |
| Almatica Pharma LLC | $42.79 | 2025 | Teriparatide |
| Amarin Pharma, INC. | $42.62 | 2022 | |
| Sequel Med Tech, LLC | $40.22 | 2025 | Twiist |
| Takeda Pharmaceuticals U.S.A., INC. | $39.53 | 2021 | |
| Zealand Pharma US, INC. | $33.58 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $32.02 | 2022-2023 | Nexlizet, Contrave, Nexletol |
| Medtronic, INC. | $30.18 | 2021 | |
| Shire North American Group INC | $28.04 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $22.57 | 2021 | |
| Nevro Corp. | $22.39 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $21.65 | 2023 | Inpefa |
| Pfizer INC. | $20.07 | 2023 | |
| Avvisto Therapeutics, LLC | $19.98 | 2025 | Cycloset |
| Tolmar, INC. | $19.57 | 2024 | |
| Alexion Pharmaceuticals, INC. | $18.55 | 2021 | |
| Bigfoot Biomedical INC | $18.52 | 2022 | |
| Medicure Pharma INC. | $17.56 | 2024 | Zypitamag |
| Vistapharm, INC. | $17.05 | 2021 | |
| Sun Pharmaceutical Industries INC. | $16.24 | 2020 | |
| Medtronic Minimed, INC. | $15.70 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $15.66 | 2019 | |
| Avion Pharmaceuticals | $13.37 | 2023 | NP Thyroid 60 |
| Esperion Therapeutics, INC. | $13.15 | 2024 | Nexletol |
| Eisai INC. | $11.05 | 2019 | |
| Echosens North America, INC. | $8.62 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Eapen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.